When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Crohn’s disease is a lifelong condition, but proper treatment ...

   www.aol.com/crohn-disease-lifelong-condition...

   Crohn’s disease and ulcerative colitis, the two main types of IBD, share many of the same symptoms. Per the CDC, common symptoms linked to IBD include diarrhea, stomach pain, fatigue, nausea and ...

3. Proctitis - Wikipedia

   en.wikipedia.org/wiki/Proctitis

   Treatment for proctitis varies depending on severity and the cause. For example, the physician may prescribe antibiotics for proctitis caused by bacterial infection. If the proctitis is caused by Crohn's disease or ulcerative colitis, the physician may prescribe the drug 5-aminosalicyclic acid (5ASA) or corticosteroids applied directly to the ...

4. Biological therapy for inflammatory bowel disease - Wikipedia

   en.wikipedia.org/wiki/Biological_therapy_for...

   It was initially used in the treatment of rheumatoid arthritis, but it is now also used in patients with moderate-to-severe Crohn's disease and ulcerative colitis who don't respond well to conventional treatment. [11] Adalimumab showed effectiveness in patients with Crohn's disease, but less than that of infliximab. [24]

5. Management of Crohn's disease - Wikipedia

   en.wikipedia.org/wiki/Management_of_Crohn's_disease

   It has been shown to be useful in the treatment of mild to moderate Crohn's disease, [6] and in maintaining remission. [7] It is also effective when used in combination with antibiotics to treat active Crohn's disease. [8] Budesonide is released in the ileum and right colon, and therefore has a topical effect against disease in that area. [6]

6. FDA-approved drug for ulcerative colitis also effective for ...

   www.aol.com/fda-approved-drug-ulcerative-colitis...

   Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, also sends Crohn's disease into clinical remission, new findings suggest.

7. FDA Approves Expanded Use Of Eli Lilly's Ulcerative Colitis ...

   www.aol.com/finance/fda-approves-expanded-eli...

   Omvoh is the first biologic treatment in more than 15 years to have disclosed two-year Phase 3 efficacy data in Crohn’s disease at the time of approval. The approval is based on results from the ...